109 related articles for article (PubMed ID: 26813456)
1. Correlation between intensity modulated radiotherapy and bone marrow suppression in breast cancer.
Wang Q; Ye T; Chen HL; Zhang XG; Zhang LZ
Eur Rev Med Pharmacol Sci; 2016; 20(1):75-81. PubMed ID: 26813456
[TBL] [Abstract][Full Text] [Related]
2. A dosimetric comparison of double-arc volumetric arc therapy, step-shoot intensity modulated radiotherapy and 3D-CRT for left-sided breast cancer radiotherapy after breast-conserving surgery.
Mo JC; Huang J; Gu WD; Gao M; Ning ZH; Mu JM; Li QL; Pei HL
Technol Health Care; 2017 Oct; 25(5):851-858. PubMed ID: 29103057
[TBL] [Abstract][Full Text] [Related]
3. Correlations Between Radiation Dose in Bone Marrow and Hematological Toxicity in Patients With Cervical Cancer: A Comparison of 3DCRT, IMRT, and RapidARC.
Chang Y; Yang ZY; Li GL; Li Q; Yang Q; Fan JQ; Zhao YC; Song YQ; Wu G
Int J Gynecol Cancer; 2016 May; 26(4):770-6. PubMed ID: 26844613
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
5. [Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy].
Shen WB; Zhu SC; Gao HM; Li YM; Liu ZK; Li J; Su JW; Wan J
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):45-9. PubMed ID: 23648300
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 3D-CRT, IMRT and VMAT radiotherapy plans for left breast cancer based on clinical dosimetric study.
Liu H; Chen X; He Z; Li J
Comput Med Imaging Graph; 2016 Dec; 54():1-5. PubMed ID: 27838084
[TBL] [Abstract][Full Text] [Related]
7. Possibility of chest wall dose reduction using volumetric-modulated arc therapy (VMAT) in radiation-induced rib fracture cases: comparison with stereotactic body radiation therapy (SBRT).
Murakami Y; Nakano M; Yoshida M; Hirashima H; Nakamura F; Fukunaga J; Hirose TA; Yoshioka Y; Oguchi M; Hirata H
J Radiat Res; 2018 May; 59(3):327-332. PubMed ID: 29800456
[TBL] [Abstract][Full Text] [Related]
8. Analysis of radiotherapy optimization regimens after modified radical mastectomy.
Zhao XB; Ren GS
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4705-4709. PubMed ID: 27906432
[TBL] [Abstract][Full Text] [Related]
9. A dosimetric analysis of tomotherapy based intensity modulated radiation therapy with and without bone marrow sparing in gynecologic malignancies.
Platta CS; Bayliss A; McHaffie D; Tome WA; Straub MR; Bradley KA
Technol Cancer Res Treat; 2013 Feb; 12(1):19-29. PubMed ID: 22974331
[TBL] [Abstract][Full Text] [Related]
10. A prospective dosimetric and clinical comparison of acute hematological toxicities in three-dimensional conformal radiation therapy and intensity modulated radiation therapy with concurrent chemotherapy in carcinoma cervix.
Avinash HU; Arul Ponni TR; Janaki MG; Kirthi Koushik AS; Kumar SM
J Cancer Res Ther; 2015; 11(1):83-7. PubMed ID: 25879342
[TBL] [Abstract][Full Text] [Related]
11. Is thyroid gland an organ at risk in breast cancer patients treated with locoregional radiotherapy? Results of a pilot study.
Tunio MA; Al Asiri M; Bayoumi Y; Stanciu LG; Al Johani N; Al Saeed EF
J Cancer Res Ther; 2015; 11(4):684-9. PubMed ID: 26881502
[TBL] [Abstract][Full Text] [Related]
12. The relationship between the radiation dose of pelvic-bone marrow and lymphocytic toxicity in concurrent chemoradiotherapy for cervical cancer.
Zhang BZ; Li Y; Xu LM; Chai YL; Qu C; Cao YJ; Wang J; Hou HL; Zhang J
Radiat Oncol; 2023 Jan; 18(1):12. PubMed ID: 36658595
[TBL] [Abstract][Full Text] [Related]
13. [Comparation study of incidental irradiation dose to the internal mammary chain during postmastectomy radiotherapy for patients treated with different irradiation techniques].
Wang W; Meng YT; Song YF; Sun T; Xu M; Shao Q; Zhang YJ; Li JB
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):335-340. PubMed ID: 29860759
[No Abstract] [Full Text] [Related]
14. [Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy].
Li JM; Yu JM; Liu SW; Chen Q; Mu XK; Jiang QA; Zhao MH; Zhang JG
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(45):3201-6. PubMed ID: 20193534
[TBL] [Abstract][Full Text] [Related]
15. Potential impact of cardiac dose-volume on acute cardiac toxicity following concurrent trastuzumab and radiotherapy.
Cao L; Hu WG; Kirova YM; Yang ZZ; Cai G; Yu XL; Ma JL; Guo XM; Shao ZM; Chen JY
Cancer Radiother; 2014 Mar; 18(2):119-24. PubMed ID: 24642505
[TBL] [Abstract][Full Text] [Related]
16. Dose-Volume Parameters of Spared Magnetic Resonance Imaging-Defined Active Bone Marrow Predict Hematologic Toxicity in Pelvic Malignancies Patients Undergoing Radiotherapy: A Cohort Study.
Gao T; Wei L; Jiang L; Ma S; Zhang W; Zhang Y; Wu F
Technol Cancer Res Treat; 2024; 23():15330338241255283. PubMed ID: 38752234
[No Abstract] [Full Text] [Related]
17. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
[TBL] [Abstract][Full Text] [Related]
18. Anterior myocardial territory may replace the heart as organ at risk in intensity-modulated radiotherapy for left-sided breast cancer.
Tan W; Liu D; Xue C; Xu J; Li B; Chen Z; Hu D; Wang X
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1689-97. PubMed ID: 21621342
[TBL] [Abstract][Full Text] [Related]
19. Radiation-induced hypothyroidism in patients with breast cancer: a retrospective analysis of 243 cases.
Kanyilmaz G; Aktan M; Koc M; Demir H; Demir LS
Med Dosim; 2017 Autumn; 42(3):190-196. PubMed ID: 28502654
[TBL] [Abstract][Full Text] [Related]
20. Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients.
Franco P; Arcadipane F; Ragona R; Lesca A; Gallio E; Mistrangelo M; Cassoni P; Arena V; Bustreo S; Faletti R; Rondi N; Morino M; Ricardi U
Med Oncol; 2016 Jul; 33(7):72. PubMed ID: 27277756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
